NASDAQ: SKINBeauty Health Co Stock
$3.06-0.09 (-2.86%)
Updated Apr 25, 2024
SKIN Price
$3.06
Fair Value Price
N/A
Market Cap
$377.69M
52 Week Low
$1.35
52 Week High
$11.73
P/E
-4.03x
P/B
6.36x
P/S
1.03x
PEG
N/A
Dividend Yield
N/A
Revenue
$397.99M
Earnings
-$100.12M
Gross Margin
39%
Operating Margin
-22.17%
Profit Margin
-25.2%
Debt to Equity
14.64
Operating Cash Flow
$22M
Beta
1.67
Next Earnings
Jun 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A
SKIN Overview
The Beauty Health Company manufactures and sells aesthetic technologies and products worldwide. The company's flagship brand, HydraFacial, created the category of hydra dermabrasion by using a patented system to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. It also offers HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time. The Beauty Health was founded in 1997 and is headquartered in Long Beach, CA.
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SKIN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SKIN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SKIN is good value based on its book value relative to its share price (6.36x), compared to the US Household & Personal Products industry average (7.38x)
P/B vs Industry Valuation
SKIN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SKIN due diligence checks available for Premium users.
Be the first to know about important SKIN news, forecast changes, insider trades & much more!
SKIN News
Valuation
SKIN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-4.03x
Industry
35.36x
Market
40.97x
SKIN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.36x
Industry
7.38x
SKIN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SKIN's financial health
Profit margin
Revenue
$96.8M
Net Income
-$9.4M
Profit Margin
-9.7%
SKIN's Earnings (EBIT) of -$88.24M... subscribe to Premium to read more.
Interest Coverage Financials
SKIN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$929.1M
Liabilities
$869.7M
Debt to equity
14.64
SKIN's short-term assets ($698.25M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SKIN's long-term liabilities ($754.72M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SKIN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$5.2M
Investing
-$2.2M
Financing
-$31.4M
SKIN's operating cash flow ($21.75M)... subscribe to Premium to read more.
Debt Coverage Financials
SKIN vs Household & Personal Product Stocks
Beauty Health Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.